Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 435,750 shares of its common stock and the grant of 240,900 restricted stock units (RSUs) to nine new employees. The awards were granted pursuant to the Nasdaq inducement grant exception as an inducement material to the employees' acceptance of employment with Verastem Oncology in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options to purchase 360,750 shares of Verastem Oncology's common stock and the 240,900 RSUs that were granted to the nine new employees will vest at a rate of twenty-five percent (25%) on the one-year anniversary of the employee's date of hire, with the remaining shares vesting quarterly over the next three (3) years in equal quarterly amounts, provided the employees continue to serve as employees of or other service providers to Verastem Oncology on each such vesting date. A stock option to purchase 75,000 shares of Verastem Oncology's common stock will vest upon the achievement of certain business milestones, provided the employee continues to serve as an employee of or other service provider to Verastem Oncology on such vesting dates. The stock options have an exercise price equal to $1.43 per share, the closing price of Verastem Oncology's common stock as reported by Nasdaq on April 1, 2022.

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. For more information, please visit www.verastem.com.


These press releases may also interest you

at 09:15
UserTesting, a SaaS leader in experience research and insights, today announced customer TULA Skincare boosted conversion rates by 300 percent with the UserTesting® Human Insight Platform. The research and design teams at TULA benefited from the rich...

at 09:15
Identity Digitaltm, a leader in connecting the online world with domain names and related technologies, today announced its partnership with Invest.Green. Invest.Green democratizes green investing by bringing institutional quality insights and...

at 09:15
Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today announced the appointment of two key executives, Jeron Evans as Chief Revenue...

at 09:15
Tigo Energy, Inc. , a leading provider of intelligent solar and energy software solutions, today announced the installation and commissioning of a rooftop solar system at its headquarters in California. The system was designed and deployed by Tigo...

at 09:10
Dexian, a leading provider of staffing, IT, and workforce solutions, today announced the launch of Dexian Futures, an online coding and career development program sponsored by Dexian. This groundbreaking program offers comprehensive instruction on...

at 09:10
Azul, the only company 100% focused on Java, today announced the recipients of its 2024 Channel Partner Awards honoring the outstanding performance and unwavering dedication of Azul's top-performing channel partners. These partners have been...



News published on and distributed by: